Drugmakers take steps to fend off future attacks
Worried about drawing Trump's ire, they aim to limit price increases and lobbying groups have pushed ahead with major campaigns intended to win back the narrative
New York
IF the nation's pharmaceutical executives thought Donald Trump would grant them a reprieve from scrutiny over high drug prices, he made them reconsider that idea in the last few days.
"I'm going to bring down drug prices," he told Time magazine in an interview published on Wednesday. "I don't like what's happened with drug prices."
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue